There is an assumption among marijuana consumers (for medical or recreational purposes) that the variations in the effects they get from the different cannabis strains are a result of variations in the THC (tetrahydrocannabinol) and CBD (cannabidiol) concentration in those strains. However, a new study has revealed that such a perception may not be a full reflection of what is going on.
The University of British Columbia-based researchers studied 33 strains of both Sativa and Indica strains of cannabis and found that there was little variation in their CBD or THC content.
However, the different strains varied widely in terms of the other cannabinoids that they contained. This finding raised the possibility that it is those other active ingredients which determine what therapeutic or psychoactive reaction a consumer will get when they consume a particular product.
Consumers need to know that cannabis has approximately 100 cannabinoids but regulations only require manufacturers to declare how much THC and CBD is present in a given product. The focus on THC and CBD may be based on the fact that those two active ingredients are the most plentiful in the cannabis plant.
However, as any lawyer will tell you, the devil is always in the details. The little-known cannabinoids could the real “heroes” of the effects that cannabis users experience.
More attention therefore needs to be focused upon understanding all the active ingredients in marijuana and how they affect a consumer.
The way cannabis strains are bred also needs to be formalized so that the scientific community can understand which strains contain which combination of active ingredients and which ones were lost during a breeding procedure.
The prohibitionist laws which have existed for long made it impossible for breeders to accurately document the lineage and characteristics of the different marijuana strains currently available. Consequently, it is possible that the same strain may have a different name based on the interests of the entity currently growing and marketing that variation of the same strain.
On the consumer side, the researchers advise that users educate themselves about the benefits of “whole plant medicine” instead of being lost in how this strain has this amount of THC or CBD when compared to another strain.
If the research achieved anything, that thing was showing the world how little is currently known about the composition, effects and uses to which marijuana can be put. You can bet that Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Sugarmade, Inc. (OTCQB: SGMD) are working to unravel the secrets marijuana has for the world.
More from CannabisNewsWire
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cannabisnewswire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
